{"entity":{"type":"insider","cik":"0001889601","url":"/insider/0001889601","json_url":"/insider/0001889601.json","name":"NSV Partners III GP LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":14,"first":"2022-11-09","last":"2023-10-11","span_basis":"filed_date"},"name_variants":[{"name":"NSV Partners III GP LLC","source":"filing","n_filings":14,"first_seen":"2022-11-09","last_seen":"2023-10-11"}],"transactions":[{"id":8502003,"accession":"0001209191-23-052627","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-052627","line_url":"/filing/0001209191-23-052627#line-1","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III GP LLC; NSV Partners III LP","owner_display_name":"NSV Partners III GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49152.0,"shares_display":"49,152","price_per_share":30.0264,"price_display":"30.03","price_state":"stated","total_value":1475857.6128,"total_display":"1,475,857.61","total_whole":"1,475,858","shares_owned_after":8439635.0,"shares_owned_after_display":"8,439,635","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-09","filed_date":"2023-10-11","scope":"insider"},{"id":8726878,"accession":"0001209191-23-050213","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050213","line_url":"/filing/0001209191-23-050213#line-1","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III LP; NSV Partners III GP LLC","owner_display_name":"NSV Partners III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56665.0,"shares_display":"56,665","price_per_share":37.8123,"price_display":"37.81","price_state":"stated","total_value":2142633.9795,"total_display":"2,142,633.98","total_whole":"2,142,634","shares_owned_after":8488787.0,"shares_owned_after_display":"8,488,787","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-18","filed_date":"2023-09-20","scope":"insider"},{"id":7922992,"accession":"0001209191-23-044050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-044050","line_url":"/filing/0001209191-23-044050#line-2","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III GP LLC; NSV Partners III LP","owner_display_name":"NSV Partners III GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10803.0,"shares_display":"10,803","price_per_share":37.5854,"price_display":"37.59","price_state":"stated","total_value":406035.0762,"total_display":"406,035.08","total_whole":"406,035","shares_owned_after":8545452.0,"shares_owned_after_display":"8,545,452","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-31","filed_date":"2023-08-01","scope":"insider"},{"id":7922989,"accession":"0001209191-23-044050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-044050","line_url":"/filing/0001209191-23-044050#line-1","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III GP LLC; NSV Partners III LP","owner_display_name":"NSV Partners III GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":611.0,"shares_display":"611","price_per_share":37.533,"price_display":"37.53","price_state":"stated","total_value":22932.663,"total_display":"22,932.66","total_whole":"22,933","shares_owned_after":8556255.0,"shares_owned_after_display":"8,556,255","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-28","filed_date":"2023-08-01","scope":"insider"},{"id":8695438,"accession":"0000950170-23-032913","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-032913","line_url":"/filing/0000950170-23-032913#line-2","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III GP LLC; NSV Partners III LP","owner_display_name":"NSV Partners III GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3275.0,"shares_display":"3,275","price_per_share":37.6242,"price_display":"37.62","price_state":"stated","total_value":123219.255,"total_display":"123,219.26","total_whole":"123,219","shares_owned_after":8556866.0,"shares_owned_after_display":"8,556,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-12","filed_date":"2023-07-13","scope":"insider"},{"id":8695436,"accession":"0000950170-23-032913","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-032913","line_url":"/filing/0000950170-23-032913#line-1","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III GP LLC; NSV Partners III LP","owner_display_name":"NSV Partners III GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28646.0,"shares_display":"28,646","price_per_share":37.5414,"price_display":"37.54","price_state":"stated","total_value":1075410.9444,"total_display":"1,075,410.94","total_whole":"1,075,411","shares_owned_after":8560141.0,"shares_owned_after_display":"8,560,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-11","filed_date":"2023-07-13","scope":"insider"},{"id":9212942,"accession":"0000950170-23-033576","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-033576","line_url":"/filing/0000950170-23-033576","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III GP LLC; NSV Partners III LP","owner_display_name":"NSV Partners III GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":35.230567636,"price_display":"35.23","price_state":"stated","total_value":3523056.7636,"total_display":"3,523,056.76","total_whole":"3,523,057","shares_owned_after":9556561.0,"shares_owned_after_display":"9,556,561","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-07","filed_date":"2023-07-19","scope":"insider","n_lines":3},{"id":8250805,"accession":"0000950170-23-032585","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-23-032585","line_url":"/filing/0000950170-23-032585","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III GP LLC; NSV Partners III LP","owner_display_name":"NSV Partners III GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":35.230567636,"price_display":"35.23","price_state":"stated","total_value":3523056.7636,"total_display":"3,523,056.76","total_whole":"3,523,057","shares_owned_after":9577279.0,"shares_owned_after_display":"9,577,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-07","filed_date":"2023-07-11","scope":"insider","n_lines":3},{"id":8457811,"accession":"0000899243-23-017237","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-23-017237","line_url":"/filing/0000899243-23-017237","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III LP; NSV Partners III GP LLC","owner_display_name":"NSV Partners III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":134080.0,"shares_display":"134,080","price_per_share":39.00431438618735,"price_display":"39.00","price_state":"stated","total_value":5229698.4729,"total_display":"5,229,698.47","total_whole":"5,229,698","shares_owned_after":9652965.0,"shares_owned_after_display":"9,652,965","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-06","scope":"insider","n_lines":5},{"id":8101617,"accession":"0000899243-23-015817","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-015817","line_url":"/filing/0000899243-23-015817#line-1","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III GP LLC; NSV Partners III LP","owner_display_name":"NSV Partners III GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":35.0757,"price_display":"35.08","price_state":"stated","total_value":1753785.0,"total_display":"1,753,785.00","total_whole":"1,753,785","shares_owned_after":9787045.0,"shares_owned_after_display":"9,787,045","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-16","scope":"insider"},{"id":8135729,"accession":"0000899243-23-015022","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-23-015022","line_url":"/filing/0000899243-23-015022","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III GP LLC; NSV Partners III LP","owner_display_name":"NSV Partners III GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35872.0,"shares_display":"35,872","price_per_share":35.65756897580285,"price_display":"35.66","price_state":"stated","total_value":1279108.3143,"total_display":"1,279,108.31","total_whole":"1,279,108","shares_owned_after":9847116.0,"shares_owned_after_display":"9,847,116","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-07","filed_date":"2023-06-08","scope":"insider","n_lines":2},{"id":8135720,"accession":"0000899243-23-015022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-015022","line_url":"/filing/0000899243-23-015022#line-1","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III GP LLC; NSV Partners III LP","owner_display_name":"NSV Partners III GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4128.0,"shares_display":"4,128","price_per_share":35.0003,"price_display":"35.00","price_state":"stated","total_value":144481.2384,"total_display":"144,481.24","total_whole":"144,481","shares_owned_after":9872917.0,"shares_owned_after_display":"9,872,917","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-06-08","scope":"insider"},{"id":8388435,"accession":"0000899243-23-011700","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-23-011700","line_url":"/filing/0000899243-23-011700#line-4","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III GP LLC; NSV Partners III LP","owner_display_name":"NSV Partners III GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":793.0,"shares_display":"793","price_per_share":38.88,"price_display":"38.88","price_state":"stated","total_value":30831.84,"total_display":"30,831.84","total_whole":"30,832","shares_owned_after":9877045.0,"shares_owned_after_display":"9,877,045","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-25","filed_date":"2023-04-25","scope":"insider"},{"id":8388431,"accession":"0000899243-23-011700","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-23-011700","line_url":"/filing/0000899243-23-011700","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III GP LLC; NSV Partners III LP","owner_display_name":"NSV Partners III GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90565.0,"shares_display":"90,565","price_per_share":38.635048094738586,"price_display":"38.64","price_state":"stated","total_value":3498983.1307,"total_display":"3,498,983.13","total_whole":"3,498,983","shares_owned_after":9877838.0,"shares_owned_after_display":"9,877,838","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-24","filed_date":"2023-04-25","scope":"insider","n_lines":2},{"id":8388422,"accession":"0000899243-23-011700","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-011700","line_url":"/filing/0000899243-23-011700#line-1","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III GP LLC; NSV Partners III LP","owner_display_name":"NSV Partners III GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8642.0,"shares_display":"8,642","price_per_share":37.5119,"price_display":"37.51","price_state":"stated","total_value":324177.8398,"total_display":"324,177.84","total_whole":"324,178","shares_owned_after":9968403.0,"shares_owned_after_display":"9,968,403","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-21","filed_date":"2023-04-25","scope":"insider"},{"id":7834301,"accession":"0000899243-23-011296","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-011296","line_url":"/filing/0000899243-23-011296#line-2","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III LP; NSV Partners III GP LLC","owner_display_name":"NSV Partners III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71446.0,"shares_display":"71,446","price_per_share":30.3138,"price_display":"30.31","price_state":"stated","total_value":2165799.7548,"total_display":"2,165,799.75","total_whole":"2,165,800","shares_owned_after":9977045.0,"shares_owned_after_display":"9,977,045","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-13","filed_date":"2023-04-14","scope":"insider"},{"id":7834298,"accession":"0000899243-23-011296","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-011296","line_url":"/filing/0000899243-23-011296#line-1","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III LP; NSV Partners III GP LLC","owner_display_name":"NSV Partners III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28554.0,"shares_display":"28,554","price_per_share":30.0086,"price_display":"30.01","price_state":"stated","total_value":856865.5644,"total_display":"856,865.56","total_whole":"856,866","shares_owned_after":10048491.0,"shares_owned_after_display":"10,048,491","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-12","filed_date":"2023-04-14","scope":"insider"},{"id":6291633,"accession":"0000899243-22-039051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-039051","line_url":"/filing/0000899243-22-039051#line-2","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III LP; NSV Partners III GP LLC","owner_display_name":"NSV Partners III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":146825.0,"shares_display":"146,825","price_per_share":32.9426,"price_display":"32.94","price_state":"stated","total_value":4836797.245,"total_display":"4,836,797.24","total_whole":"4,836,797","shares_owned_after":12974786.0,"shares_owned_after_display":"12,974,786","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-16","filed_date":"2022-12-19","scope":"insider"},{"id":6291629,"accession":"0000899243-22-039051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-039051","line_url":"/filing/0000899243-22-039051#line-1","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III LP; NSV Partners III GP LLC","owner_display_name":"NSV Partners III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":153175.0,"shares_display":"153,175","price_per_share":33.6101,"price_display":"33.61","price_state":"stated","total_value":5148227.0675,"total_display":"5,148,227.07","total_whole":"5,148,227","shares_owned_after":13121611.0,"shares_owned_after_display":"13,121,611","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-19","scope":"insider"},{"id":6118249,"accession":"0000899243-22-037468","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-037468","line_url":"/filing/0000899243-22-037468#line-2","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III GP LLC; NSV Partners III LP","owner_display_name":"NSV Partners III GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":129317.0,"shares_display":"129,317","price_per_share":29.0074,"price_display":"29.01","price_state":"stated","total_value":3751149.9458,"total_display":"3,751,149.95","total_whole":"3,751,150","shares_owned_after":16616048.0,"shares_owned_after_display":"16,616,048","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-02","scope":"insider"},{"id":6118247,"accession":"0000899243-22-037468","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-037468","line_url":"/filing/0000899243-22-037468#line-1","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III GP LLC; NSV Partners III LP","owner_display_name":"NSV Partners III GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":143228.0,"shares_display":"143,228","price_per_share":29.0148,"price_display":"29.01","price_state":"stated","total_value":4155731.7744,"total_display":"4,155,731.77","total_whole":"4,155,732","shares_owned_after":16745365.0,"shares_owned_after_display":"16,745,365","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-30","filed_date":"2022-12-02","scope":"insider"},{"id":6118095,"accession":"0000899243-22-035456","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-035456","line_url":"/filing/0000899243-22-035456#line-1","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":null,"owner_name":"NSV Partners III LP; NSV Partners III GP LLC","owner_display_name":"NSV Partners III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3935.0,"shares_display":"3,935","price_per_share":29.0794,"price_display":"29.08","price_state":"stated","total_value":114427.439,"total_display":"114,427.44","total_whole":"114,427","shares_owned_after":16888593.0,"shares_owned_after_display":"16,888,593","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-07","filed_date":"2022-11-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001851194","name":"Ventyx Biosciences, Inc.","url":"/issuer/0001851194","role":"Ten percent owner","n_filings":14,"first_seen":"2022-11-09","last_seen":"2023-10-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001889601","retrieved_at":"2026-08-25T09:23:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}